Considering the above-mentioned products of oxidation, which can activate the complement cascade and upregulate VEGF, an effective antioxidant therapy can decrease the risk of the formation of such oxidation products, and therefore act upstream of these deleterious effects thereby preventing complement activation and excessive secretion of VEGF, both of which are held responsible for the development of AMD. Here, VEGFA is linked to age-related macular degeneration.